Related Experiment Video
Updated: Jun 24, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Clostridium difficile 30 years on: what has, or has not, changed and why?
1Research Service, Edward Hines Jr. Veterans Affairs Hospital, 5000 S. 5th Avenue, Building 1, Room C344, Hines, IL 60141, USA. dale.gerding2@va.gov
Clostridium difficile infection (CDI) has resurged globally, with higher morbidity and mortality. Understanding the host-organism interaction is key to developing new prevention and treatment strategies for this antibiotic-associated colitis.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Clindamycin-associated colitis, reported in 1974, prompted research into its cause.
- In 1978, Clostridium difficile and its toxins were identified as the causative agents.
- Antibiotic use has historically been linked to this severe gastrointestinal complication.
Observation:
- A significant resurgence of Clostridium difficile infection (CDI) is occurring in North America and Europe.
- Current CDI cases exhibit higher morbidity and mortality rates than previously reported.
- This resurgence contrasts with the perceived manageability of the disease 30 years ago.
Findings:
- Over the past 30 years, significant discoveries have advanced the understanding of CDI pathogenesis.
- Key breakthroughs include identifying Clostridium difficile and its toxins.
- Research has focused on the relationship between the organism and the host at the mucosal level.
Implications:
- Future research should prioritize understanding the host-organism interaction at the mucosal level.
- Development of novel biotherapeutic and vaccine strategies for CDI prevention is crucial.
- Addressing the rising incidence and severity of CDI requires a deeper scientific understanding.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Development of Human Microbiota
History of Microbiology
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Evolution of New Traits in Microbes
